Hepatitis B reactivation after switch to injectable treatment: rare, but proceed with caution
Injectable HIV treatment does as well as daily pills in real-world settings
Dolutegravir resistance has not risen in Lesotho cohort
European guidelines widen access to two-drug HIV treatment
A pair of antibodies keeps HIV undetectable by ‘bolting the door and masking the key’
“Normal is the perfect word”: participants describe switching to weekly HIV treatment
From “good news” to “failure”: how French participants experienced an HIV remission trial
'We finally understand what we have to do': antibody studies point the way to an HIV cure
Lean people with HIV can still develop fatty liver disease